BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38190092)

  • 1. Multi-omics analyses of choroid plexus carcinoma cell lines reveal potential targetable pathways and alterations.
    Hesham D; On J; Alshahaby N; Amer N; Magdeldin S; Okada M; Tsukamoto Y; Hiraishi T; Imai C; Okuda S; Wakai T; Kakita A; Oishi M; El-Naggar S; Natsumeda M
    J Neurooncol; 2024 Jan; 166(1):27-38. PubMed ID: 38190092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors.
    Tabori U; Shlien A; Baskin B; Levitt S; Ray P; Alon N; Hawkins C; Bouffet E; Pienkowska M; Lafay-Cousin L; Gozali A; Zhukova N; Shane L; Gonzalez I; Finlay J; Malkin D
    J Clin Oncol; 2010 Apr; 28(12):1995-2001. PubMed ID: 20308654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of choroid plexus tumors reveals novel clinically relevant subgroups.
    Merino DM; Shlien A; Villani A; Pienkowska M; Mack S; Ramaswamy V; Shih D; Tatevossian R; Novokmet A; Choufani S; Dvir R; Ben-Arush M; Harris BT; Hwang EI; Lulla R; Pfister SM; Achatz MI; Jabado N; Finlay JL; Weksberg R; Bouffet E; Hawkins C; Taylor MD; Tabori U; Ellison DW; Gilbertson RJ; Malkin D
    Clin Cancer Res; 2015 Jan; 21(1):184-92. PubMed ID: 25336695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new genetically engineered mouse model of choroid plexus carcinoma.
    El Nagar S; Zindy F; Moens C; Martin L; Plassard D; Roussel MF; Lamonerie T; Billon N
    Biochem Biophys Res Commun; 2018 Feb; 496(2):568-574. PubMed ID: 29339161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation signature is prognostic of choroid plexus tumor aggressiveness.
    Pienkowska M; Choufani S; Turinsky AL; Guha T; Merino DM; Novokmet A; Brudno M; Weksberg R; Shlien A; Hawkins C; Bouffet E; Tabori U; Gilbertson RJ; Finlay JL; Jabado N; Thomas C; Sill M; Capper D; Hasselblatt M; Malkin D
    Clin Epigenetics; 2019 Aug; 11(1):117. PubMed ID: 31409384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetic landscape of choroid plexus tumors in children and adults.
    Thomas C; Soschinski P; Zwaig M; Oikonomopoulos S; Okonechnikov K; Pajtler KW; Sill M; Schweizer L; Koch A; Neumann J; Schüller U; Sahm F; Rauschenbach L; Keyvani K; Proescholdt M; Riemenschneider MJ; Segewiß J; Ruckert C; Grauer O; Monoranu CM; Lamszus K; Patrizi A; Kordes U; Siebert R; Kool M; Ragoussis J; Foulkes WD; Paulus W; Rivera B; Hasselblatt M
    Neuro Oncol; 2021 Apr; 23(4):650-660. PubMed ID: 33249490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutional mosaicism of a de novo TP53 mutation in a patient with bilateral choroid plexus carcinoma.
    Trubicka J; Filipek I; Iwanowski P; Rydzanicz M; Grajkowska W; Piekutowska-Abramczuk D; Chrzanowska K; Karkucińska-Więckowska A; Iwanicka-Pronicka K; Pronicki M; Łastowska M; Płoski R; Dembowska-Bagińska B
    Cancer Genet; 2017 Oct; 216-217():79-85. PubMed ID: 29025599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular heterogeneity of pediatric choroid plexus carcinomas determines the distinctions in clinical course and prognosis.
    Zaytseva M; Valiakhmetova A; Yasko L; Samarin A; Papusha L; Shekhtman A; Usman N; Voronin K; Karachunskiy A; Novichkova G; Druy A
    Neuro Oncol; 2023 Jun; 25(6):1132-1145. PubMed ID: 36534940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic profile of two Brazilian choroid plexus tumors by whole-exome sequencing.
    Garcia FAO; Evangelista AF; Mançano BM; Moreno DA; Berardinelli GN; de Paula FE; Antoniazzi AP; Júnior CA; Lombardi I; Santana I; Teixeira GR; Costa CE; Reis RM
    Cold Spring Harb Mol Case Stud; 2023 Feb; 9(1):. PubMed ID: 36963804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myc and Loss of p53 Cooperate to Drive Formation of Choroid Plexus Carcinoma.
    Wang J; Merino DM; Light N; Murphy BL; Wang YD; Guo X; Hodges AP; Chau LQ; Liu KW; Dhall G; Asgharzadeh S; Kiehna EN; Shirey RJ; Janda KD; Taylor MD; Malkin D; Ellison DW; VandenBerg SR; Eberhart CG; Sears RC; Roussel MF; Gilbertson RJ; Wechsler-Reya RJ
    Cancer Res; 2019 May; 79(9):2208-2219. PubMed ID: 30885981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular insights into malignant progression of atypical choroid plexus papilloma.
    Yankelevich M; Finlay JL; Gorsi H; Kupsky W; Boue DR; Koschmann CJ; Kumar-Sinha C; Mody R
    Cold Spring Harb Mol Case Stud; 2021 Feb; 7(1):. PubMed ID: 33608379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of TP53 expression in immortalized choroid plexus epithelial cells results in increased resistance to anticancer agents.
    Krzyzankova M; Mertsch S; Koos B; Jeibmann A; Kruse A; Kordes U; Frühwald MC; Wolff JE; Paulus W; Hasselblatt M
    J Neurooncol; 2012 Sep; 109(3):449-55. PubMed ID: 22763759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetics impacts upon prognosis and clinical management of choroid plexus tumors.
    Thomas C; Metrock K; Kordes U; Hasselblatt M; Dhall G
    J Neurooncol; 2020 May; 148(1):39-45. PubMed ID: 32342334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroups.
    Thomas C; Sill M; Ruland V; Witten A; Hartung S; Kordes U; Jeibmann A; Beschorner R; Keyvani K; Bergmann M; Mittelbronn M; Pietsch T; Felsberg J; Monoranu CM; Varlet P; Hauser P; Olar A; Grundy RG; Wolff JE; Korshunov A; Jones DT; Bewerunge-Hudler M; Hovestadt V; von Deimling A; Pfister SM; Paulus W; Capper D; Hasselblatt M
    Neuro Oncol; 2016 Jun; 18(6):790-6. PubMed ID: 26826203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical validation of a novel therapeutic strategy for choroid plexus carcinoma.
    Martin B; Garman T; Laramee M; Wang A; Zhang X; Beck E; Wilson K; Klumpp-Thomas C; McKnight C; Xu X; Hagen N; Holland D; Dahmane N; Thomas CJ; Souweidane M
    J Control Release; 2023 May; 357():580-590. PubMed ID: 37054779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of proliferative index and cell cycle protein expression in choroid plexus tumors in children.
    Carlotti CG; Salhia B; Weitzman S; Greenberg M; Dirks PB; Mason W; Becker LE; Rutka JT
    Acta Neuropathol; 2002 Jan; 103(1):1-10. PubMed ID: 11837741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of choroid plexus carcinoma cell lines: connection between choroid plexus and immune systems.
    Enjoji M; Iwaki T; Hara H; Sakai H; Nawata H; Watanabe T
    Jpn J Cancer Res; 1996 Sep; 87(9):893-9. PubMed ID: 8878450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Widely Metastatic Choroid Plexus Carcinoma Associated with Novel TP53 Somatic Mutation.
    Baksh BS; Sinha N; Salehi A; Han RH; Miller BA; Dahiya S; Gauvain KM; Limbrick DD
    World Neurosurg; 2018 Nov; 119():233-236. PubMed ID: 30099178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choroid plexus carcinomas are characterized by complex chromosomal alterations related to patient age and prognosis.
    Ruland V; Hartung S; Kordes U; Wolff JE; Paulus W; Hasselblatt M
    Genes Chromosomes Cancer; 2014 May; 53(5):373-80. PubMed ID: 24478045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moderate-to-strong expression of FGFR3 and TP53 alterations in a subpopulation of choroid plexus tumors.
    Granberg KJ; Raita A; Lehtinen B; Tiihonen AM; Kesseli J; Annala M; Rodriguez-Martinez A; Nordfors K; Zhang W; Visakorpi T; Nykter M; Haapasalo H
    Histol Histopathol; 2020 Jul; 35(7):673-680. PubMed ID: 31660579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.